中兵紅箭(000519.SZ):截至目前,公司沒有資產注入事項
格隆匯8月13日丨中兵紅箭(000519.SZ)在互動平台表示,公司特種裝備板塊堅決服從和服務於國防和軍隊現代化的需要,在專業領域達到行業領先水平,部分產品為國內獨家生產;超硬材料板塊作為國家明確的戰新產業,應用前景廣闊,相關產品綜合競爭實力、技術能力均居全球領先。2025年營收目標是公司根據現有手持訂單、意向訂單和相關行業市場行情做出的前瞻性判斷,不代表對公司2025年業績的預測。截至目前,公司沒有資產注入事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.